Trademark: 79386772
Word
PHAROS IBIO
Status
Pending
Status Code
641
Status Date
Thursday, April 11, 2024
Serial Number
79386772
Mark Type
3
Filing Date
Wednesday, September 6, 2023

Trademark Owner History

Classifications
5 Vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; reagents and media for medical and veterinary diagnostic purposes; medicinal healthcare preparations; pharmaceutical drugs; diagnostic agents for pharmaceutical use; medicinal creams; synthetic peptides for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; pharmaceutical compositions; pharmaceuticals; human vaccine preparations; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of immune system related diseases and disorders; nutraceuticals for therapeutic purposes; therapeutic drugs and agents; anti-cancer preparations
42 Scientific research conducted using databases; research and development of vaccines and medicines; analysis in the field of molecular biology; development of computer software for big data processing; research and development of technology for biotechnology; consultancy in the field of biotechnology; research relating to biotechnology; advisory services relating to biotechnology; biotechnology services; biological information check (genetic testing for scientific research purposes); biological information check (genetic testing for medical research purposes); platform as a service [PaaS]; development of cell therapy products; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; research in the field of pharmacogenetics; pharmaceutical research and development; pharmaceutical research services; scientific research in the field of pharmacy; toxicity testing for research purposes; providing technological consultancy relating to design and development of medical diagnostic instruments; providing computer software technical support services in the field of medical diagnostics; medicine research; providing information on the testing, inspection, and research of medical products, consultancy in the field of testing, inspection, and research of medical products; medical and pharmacological research services; scientific research in the fields of medicine, and health and pharmacology; design and development of programs for computers
The non-Latin characters in the mark transliterate to "PHAROS IBIO".

Trademark Events
Jan 4, 2024
Sn Assigned For Sect 66a Appl From Ib
Jan 5, 2024
New Application Office Supplied Data Entered
Jan 9, 2024
Application Filing Receipt Mailed
Mar 18, 2024
Assigned To Examiner
Mar 22, 2024
Non-Final Action Written
Mar 23, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Apr 11, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Apr 11, 2024
Refusal Processed By Mpu
May 1, 2024
Refusal Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24